| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.166.16.1739 |
| P698 | PubMed publication ID | 16983052 |
| P50 | author | Simone Fulda | Q21264686 |
| Jakob Linseisen | Q28360658 | ||
| Hubertus Himmerich | Q47421869 | ||
| P2093 | author name string | Pierre A Beitinger | |
| Thomas C Wetter | |||
| Thomas Pollmächer | |||
| Günther Wolfram | |||
| Renate Wehrle | |||
| Kurt Gedrich | |||
| Stephanie Himmerich | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | narcolepsy | Q189561 |
| P304 | page(s) | 1739-1743 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy | |
| P478 | volume | 166 |
| Q64241077 | Cytokine Research in Depression: Principles, Challenges, and Open Questions |
| Q36817960 | Elevated peripheral visfatin levels in narcoleptic patients |
| Q34413665 | Etiopathogenesis and neurobiology of narcolepsy: a review |
| Q37415263 | High-dimensional single-cell analysis reveals the immune signature of narcolepsy. |
| Q42456089 | Hypothalamo-pituitary-adrenal axis, glucose metabolism and TNF-α in narcolepsy. |
| Q24683590 | Identification of differentially expressed genes in blood cells of narcolepsy patients |
| Q94464141 | Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis |
| Q36059560 | Improved Sleep Efficiency after Anti-Tumor Necrosis Factor α Therapy in Rheumatoid Arthritis Patients |
| Q30371742 | Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases. |
| Q37310533 | Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. |
| Q37686605 | Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro |
| Q92448025 | Molecular mechanism of tumour necrosis factor alpha regulates hypocretin (orexin) expression, sleep and behaviour |
| Q41995022 | Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment. |
| Q35212990 | Narcolepsy: a review |
| Q26864449 | Neuroendocrine immunoregulation in multiple sclerosis |
| Q38038156 | Obstructive sleep apnoea in relation to rheumatic disease |
| Q48210322 | Plasma obestatin and autonomic function are altered in orexin-deficient narcolepsy, but ghrelin is unchanged |
| Q48453294 | Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications |
| Q38096025 | Systems level immune response analysis and personalized medicine |
| Q34608619 | The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology |
| Q26851982 | The role of orexin in post-stroke inflammation, cognitive decline, and depression |
| Q34590104 | Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitination |
Search more.